Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria

被引:57
作者
Yilmaz, Mehmet [1 ]
Isaoglu, Unal [1 ]
Delibas, Ilhan Bahri [2 ]
Kadanali, Sedat [2 ]
机构
[1] Nenehatun Kadin Hastaliklari & Dogum Hastanesi, TR-25060 Erzurum, Turkey
[2] Ataturk Univ, Dept Obstet & Gynecol, Aziziye Resarch Hosp, Erzurum, Turkey
关键词
anthropometrical; hormonal; metabolic; phenotypes; polycystic ovary syndrome; 2003; CONSENSUS; WOMEN;
D O I
10.1111/j.1447-0756.2010.01478.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To compare all phenotypes of polycystic ovary syndrome (PCOS) for anthropometrical, hormonal, and metabolic differences according to Rotterdam criteria. Material & Methods: Women with PCOS (Rotterdam definition; n = 127) and women without PCOS used as controls (n = 44). There were four phenotypes of PCOS: 56/127 (44.09%) of the patients were polycystic ovaries on ultrasound (PCO) + oligo or anovulation (O) + biochemical and/or clinical hyperandrogenism (HA), 29/127 (22.84%) were HA+O, 24/127 (18.90%) were PCO+O and 18/127 (14.17%) were HA+PCO. And 42/127 (33.07%) patients represented the new phenotypes (PCO+O and HA+PCO). Phenotypical, hormonal and metabolic parameters were compared between the groups. Results: Waist-to-hip ratio, luteinizing hormone-to-follicle stimulating hormone ratio, testosterone, androstenedione, dehydroepiandrostenedione were lower in women with PCO+O and controls than the other three phenotypes. The highest score regarding hirsutismus was found in the HA+O phenotype and the lowest score in the PCO+O phenotype. Prevalence of metabolic syndrome and degree of insulin resistance in PCO+O phenotype was closer to control subjects than the other three phenotypes. Conclusions: Anthropometrical, hormonal, and metabolic differences suggest that PCO+O phenotype is closer to control group than the other PCOS phenotypes.
引用
收藏
页码:1020 / 1026
页数:7
相关论文
共 17 条
[1]   Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? [J].
Belosi, C. ;
Selvaggi, L. ;
Apa, R. ;
Guido, M. ;
Romualdi, D. ;
Fulghesu, A. M. ;
Lanzone, A. .
HUMAN REPRODUCTION, 2006, 21 (12) :3108-3115
[2]  
Çaliskan E, 2007, J TURK-GER GYNECOL A, V8, P402
[3]   Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women [J].
Chae, Soo Jin ;
Kim, Jin Ju ;
Choi, Young Min ;
Hwang, Kyu Ri ;
Jee, Byung Chul ;
Ku, Seung Yup ;
Suh, Chang Suk ;
Kim, Seok Hyun ;
Kim, Jung Gu ;
Moon, Shin Yong .
HUMAN REPRODUCTION, 2008, 23 (08) :1924-1931
[4]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[5]  
Chang WY, 2005, FERTIL STERIL, V83, P1343
[6]   Oligoanovulation with polycystic ovaries but not overt hyperandrogenism [J].
Dewailly, Didier ;
Catteau-Jonard, Sophie ;
Reyss, Anne-Celine ;
Leroy, Maryse ;
Pigny, Pascal .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10) :3922-3927
[7]   MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME [J].
FRANKS, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :853-861
[8]   Detection of insulin resistance in Turkish adults: a hospital-based study [J].
Gokcel, A ;
Baltali, M ;
Tarim, E ;
Bagis, T ;
Gumurdulu, Y ;
Karakose, H ;
Yalcin, F ;
Akbaba, M ;
Guvener, N .
DIABETES OBESITY & METABOLISM, 2003, 5 (02) :126-130
[9]   HIRSUTISM - IMPLICATIONS, ETIOLOGY, AND MANAGEMENT [J].
HATCH, R ;
ROSENFIELD, RL ;
KIM, MH ;
TREDWAY, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 140 (07) :815-830
[10]  
JOYCE K, 2006, J MIDWIFERY WOM HEAL, V51, P415